Novartis (NVS) Drops 3.5% in a Single Session to $150.55
As seen on the 24/7 Wall St. homepage on October 23, 2026.
A 3.54% slide to $150.55 wipes roughly $10 billion off a $286 billion pharma name that rarely moves this much in a single session. Defensive large-cap drugmakers trading like this is worth a look before the close.
Continue ReadingShow less
Novartis fell from its $156.08 open to around $150.53 in minutes, then held the low $150s for the rest of the afternoon without recovering.
A 3.54% single-session decline at this scale erases roughly $10 billion in market value. Defensive large-cap drugmakers rarely move this much without the market paying close attention.
Sponsored
A tight range followed by a vertical drop in two consecutive intervals points to a specific catalyst behind the selling.
For holders, the question is whether the low $150s becomes a new range or a pause before further pressure. For anyone on the sidelines, a move this size in a name known for stability warrants a closer look before the close.
Sources
Mentioned: NVS